Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STN1014200 Ophthalmic Emulsion for Pterygium
jRCT2031250504Recruiting
- Sponsor
- Santen Pharmaceutical
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of STN1014200 in pterygium (3 arms), sponsored by Santen Pharmaceutical. Primary endpoint: Percent change in pterygium lesion length from baseline to Month 6. Started Dec 2025; status: recruiting.
02
Drugs
STN1014200
03
Conditions
pterygium
Beyond the preview
Go deeper on jRCT2031250504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250504.